Labcorp Holdings Inc. logo
Labcorp Holdings Inc. (LH)
Compare

LH Dividends

Labcorp Holdings Inc. (LH) pays $2.88 in dividends per share, with a current dividend yield of 1.08%.

LH Dividend Summary

Consecutive Years

0

Most Recent Ex-Date

May 29, 2026

Most Recent Payment

Jun 11, 2026

LH Dividends per Share (Nominal History)

View full nominal table list

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.

LH Dividends CAGR Chart

Labcorp Holdings Inc. (LH)

Annual Dividend History

YearDividend/ShareYoY Growth
2026(YTD)$1.44
2025$2.88+0.00%
2024$2.88+7.58%
2023$2.68N/A
2022$1.86N/A
1994$0.17N/A
1993$0.69N/A
1992$0.82N/A
1991$0.43N/A
1990$0.13N/A

Quarterly Dividend History

QuarterDividend/ShareYoY Growth
Q2 2026$0.72+0.00%
Q1 2026$0.72+0.00%
Q4 2025$0.72+0.00%
Q3 2025$0.72+0.00%
Q2 2025$0.72+0.00%
Q1 2025$0.72+0.00%
Q4 2024$0.72+0.00%
Q3 2024$0.72+0.00%
Q2 2024$0.72+16.40%
Q1 2024$0.72+16.40%
Q4 2023$0.72+16.40%
Q3 2023$0.72+16.40%
Q2 2023$0.62+0.00%
Q1 2023$0.62
Q4 2022$0.62
Q3 2022$0.62
Q2 2022$0.62
Q1 1994$0.17+0.00%
Q4 1993$0.17+0.00%
Q3 1993$0.17+0.00%
Q2 1993$0.17+0.00%
Q1 1993$0.17
Q4 1992$0.17
Q3 1992$0.17+14.29%

Dividend Yield Metrics

Current Yield
1.08%
Average Yield (TTM)
1.08%
Average Yield (3Y)
1.06%
Forward Yield on Cost (3Y)
18.14%
Forward Yield on Cost (5Y)
118.79%
Forward Yield on Cost (10Y)
13041.04%

Payout Ratio Analysis

Payout Ratio (Current)
27.32%
FCF Payout Ratio
17.31%
Payout Ratio (3Y Avg)
38.50%
Payout Ratio (5Y Avg)
< 5Y history
FCF Payout (3Y Avg)
22.86%
FCF Payout (5Y Avg)
< 5Y history

Dividend Coverage

Payout Ratio
27.3%
Dividends / net income
FCF Payout Ratio
17.3%
Dividends / free cash flow
Consecutive Years
N/A
Years with regular dividend payments
5Y Dividend Growth
9.5%
Compound annual dividend growth

About Labcorp Holdings Inc.

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Burlington, NC
60,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Adam H. Schechter